Asthma Clinical Research Studies
Interested in joining a clinical research trial?
Treatment options for asthma continue to evolve. Currently, our center has multiple asthma studies for treatments that include: investigational inhalers for children, generic versions of already marketed medication, oral medications as add-on therapy, injections as add-on therapy, and biologics (complicated molecules that are manufactured within a living organism). Each of these asthma studies offer unique treatment opportunities for patients with mild to extremely severe asthma. These medications are provided at absolutely no cost, with no insurance needed. You may also be reimbursed for your time and travel and will receive care from physicians affiliated with the Clinical Research Center of Alabama.
A 12 week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care therapy in patients with uncontrolled asthma.
Investigational Inhaler Study
This study is to evaluate the efficacy of an investigational product or use in the treatment of asthma. This is an orally inhaled product called Glycopoyrronium Inhalation Aerosol (also known as GP metered dose inhaler (MDI) or PT001). A MDI is a handheld device that delivers a specific amount of medication to the lungs by inhaling through the mouth.
The purpose of this study is to collect information to help us understand how doctors treat and manage people with severe asthma and how the health of people with severe asthma changes with those treatments. In this study, no specific treatment or research drug is given, but your normal care and assessments are recorded. The length of each patient’s participation will vary but the goal is to have patients involved for 3 or more years.
Oral Medication - Add-On Therapy
The purpose of this research study is to test the safety and efficacy of a potential treatment called GB001 when added to the asthma medications you are currently prescribed. You are being asked to take part in this study because you have moderate to severe asthma that is not being fully controlled by the medicines that you are currently taking.
The primary objective of this study is to evaluate the efficacy of dupilumab in children 6 to 12 years of age with uncontrolled persistent asthma.
Become a Participant in our Asthma Studies
If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.